Status:

COMPLETED

Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Covid-19

Family Members

Eligibility:

All Genders

18+ years

Brief Summary

To limit the pandemic Covid-19 infection, the French government imposed a closure of all Intensive Care Unit (ICU). The family's visitations are prohibited during active Covid -19 pandemic in 2020 and...

Detailed Description

Observational multicenter study Three groups are compared: * no visitation group. Enrollment during the application of national containment measures to limit Covid pandemic in France: March to June ...

Eligibility Criteria

Inclusion

  • Relative of patient who was admitted in ICU and treated with invasive mechanical ventilation administration during 24hours at least.

Exclusion

  • Relative who declines the enrollment

Key Trial Info

Start Date :

June 22 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 9 2022

Estimated Enrollment :

811 Patients enrolled

Trial Details

Trial ID

NCT04430049

Start Date

June 22 2020

End Date

November 9 2022

Last Update

February 8 2023

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

University hospital, Clermont-Ferrand

Clermont-Ferrand, Auvergne, France, 63000

2

CH Aurillac

Aurillac, France, 15000

3

CH Cannes

Cannes, France, 06150

4

Centre Jean Perrin

Clermont-Ferrand, France, 63000